Earnings calendar/HIMS
Hims & Hers Health, Inc. (HIMS)
Quarter-by-quarter results read from the company's own filed statements — period end, filing date, diluted EPS, revenue and year-over-year change. Consensus estimates are shown only where one exists.
Latest filed quarter
The most recent quarter Hims & Hers Health, Inc. has filed, from EvidInvest's standardized statements.
Period end
Jun 30, 2026
Q2 FY2026
EPS (diluted)
$-0.37
Est. $-0.05 · -643.0%
Revenue
$753.2M
Est. $698.9M · +7.8%
Net income
$-86.3M
As filed
EPS YoY
-317.6%
vs quarter ended 2025-06-30
Revenue YoY
+38.2%
vs quarter ended 2025-06-30
Next report
Nov 9, 2026
Third-party calendar date, not confirmed by a company filing · est. EPS $0.07
Run-rate
Trailing twelve months, summed from the last four filed quarters.
TTM EPS (diluted)
$-0.63
2025-09-30 through 2026-06-30
TTM revenue
$2.58B
2025-09-30 through 2026-06-30
Filed quarters
30
On record here
EPS at or above estimate (4Q)
25%
Of the last four quarters that carry an estimate
Filed quarters
One row per filed statement, newest first
| Period end | Filed | EPS diluted | Revenue | EPS YoY | Revenue YoY | Est. EPS | Surprise |
|---|---|---|---|---|---|---|---|
| 2026-06-30Q2 FY2026 | 2026-08-10 | $-0.37 | $753.2M | -317.6% | +38.2% | $-0.05 | -643.0% |
| 2026-03-31Q1 FY2026 | 2026-05-11 | $-0.40 | $608.1M | -300.0% | +3.8% | $0.03 | -1674.8% |
| 2025-12-31Q4 FY2025 | 2026-02-23 | $0.08 | $617.8M | -20.0% | +28.4% | $0.02 | +300.0% |
| 2025-09-30Q3 FY2025 | 2025-11-03 | $0.06 | $599.0M | -81.3% | +49.2% | $0.09 | -33.3% |
| 2025-06-30Q2 FY2025 | 2025-08-04 | $0.17 | $544.8M | +183.3% | +72.6% | $0.18 | -5.6% |
| 2025-03-31Q1 FY2025 | 2025-05-05 | $0.20 | $586.0M | +300.0% | +110.7% | $0.12 | +65.4% |
| 2024-12-31Q4 FY2024 | 2025-02-24 | $0.10 | $481.1M | +900.0% | +95.1% | $0.09 | +11.1% |
| 2024-09-30Q3 FY2024 | 2024-11-04 | $0.32 | $401.6M | +900.0% | +77.1% | $0.06 | +433.3% |
| 2024-06-30Q2 FY2024 | 2024-08-05 | $0.06 | $315.6M | +300.0% | +51.8% | $0.04 | +40.5% |
| 2024-03-31Q1 FY2024 | 2024-05-06 | $0.05 | $278.2M | +200.0% | +45.8% | $0.01 | +316.7% |
| 2023-12-31Q4 FY2023 | 2024-02-26 | $0.01 | $246.6M | +120.0% | +47.5% | $0.00 | +150.0% |
| 2023-09-30Q3 FY2023 | 2023-11-06 | $-0.04 | $226.7M | +55.6% | +56.5% | $-0.03 | -27.4% |
| 2023-06-30Q2 FY2023 | 2023-08-07 | $-0.03 | $207.9M | +70.0% | +83.1% | $-0.05 | +40.0% |
| 2023-03-31Q1 FY2023 | 2023-05-08 | $-0.05 | $190.8M | +37.5% | +88.3% | $-0.07 | +28.6% |
| 2022-12-31Q4 FY2022 | 2023-02-27 | $-0.05 | $167.2M | +54.5% | +97.4% | $-0.07 | +28.6% |
| 2022-09-30Q3 FY2022 | 2022-11-07 | $-0.09 | $144.8M | -12.5% | +95.3% | $-0.10 | +10.0% |
| 2022-06-30Q2 FY2022 | 2022-08-08 | $-0.10 | $113.6M | -100.0% | +87.1% | $-0.10 | 0.0% |
| 2022-03-31Q1 FY2022 | 2022-05-09 | $-0.08 | $101.3M | +76.5% | +93.7% | $-0.07 | -14.3% |
| 2021-12-31Q4 FY2021 | 2022-02-24 | $-0.11 | $84.7M | +26.7% | +104.3% | $-0.10 | -10.0% |
| 2021-09-30Q3 FY2021 | 2021-11-10 | $-0.08 | $74.2M | +50.0% | +79.5% | — | — |
| 2021-06-30Q2 FY2021 | 2021-08-11 | $-0.05 | $60.7M | -66.7% | +69.0% | — | — |
| 2021-03-31Q1 FY2021 | 2021-05-17 | $-0.34 | $52.3M | -100.0% | +74.0% | — | — |
| 2020-12-31Q4 FY2020 | 2021-03-22 | $-0.15 | $41.5M | +6.3% | +67.4% | — | — |
| 2020-09-30Q3 FY2020 | 2020-11-13 | $-0.16 | $41.3M | +33.3% | +90.6% | — | — |
| 2020-06-30Q2 FY2020 | 2020-08-13 | $-0.03 | $35.9M | — | +98.9% | — | — |
| 2020-03-31Q1 FY2020 | 2020-05-14 | $-0.17 | $30.1M | +37.0% | +66.5% | — | — |
| 2019-12-31Q4 FY2019 | 2020-03-27 | $-0.16 | $24.8M | — | — | — | — |
| 2019-09-30Q3 FY2019 | 2019-11-12 | $-0.24 | $21.7M | — | — | — | — |
| 2019-06-30Q2 FY2019 | 2019-08-29 | $0.00 | $18.1M | — | — | — | — |
| 2019-03-31Q1 FY2019 | 2019-03-31 | $-0.27 | $18.1M | — | — | — | — |
Need HIMS data in your own agent or pipeline?
The earnings data on this page — report dates, filed EPS/revenue actuals and run-rate history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.